Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Serotonin plays a crucial role in regulating various central nervous system functions, including appetite.
• Understanding the mechanisms of appetite regulation is vital for addressing metabolic disorders.

Purpose of the Study:

• To investigate the neurochemical effects of meta-chlorophenylpiperazine (mCPP) on monoamine uptake and release.
• To determine the role of serotonin in the appetite-suppressing effects of mCPP.
• To evaluate mCPP as a potential pharmacological tool for neuroscience research.

Main Methods:

• Inhibition assays for serotonin, noradrenaline, and dopamine uptake in synaptosomes.
• Monoamine release studies in synaptosomal preparations.
• Radioligand binding assays to assess 3H-5HT binding.
• Behavioral studies measuring food intake in response to mCPP administration.
• Pharmacological interventions including serotonin antagonists and neurochemical lesions.

Main Results:

• mCPP potently inhibited serotonin and noradrenaline uptake, with less effect on dopamine uptake.
• mCPP demonstrated high affinity for serotonin receptors, displacing 3H-5HT binding.
• mCPP dose-dependently reduced food intake, an effect blocked by the serotonin antagonist methergoline.
• The appetite-reducing effects were independent of dopaminergic or noradrenergic pathways.

Conclusions:

• mCPP acts as a serotonin agonist in the brain, leading to reduced food intake.
• The findings highlight the critical role of serotonin in appetite regulation.
• mCPP is a valuable and specific pharmacological tool for exploring the functional significance of serotonin in the central nervous system.